W
Wendy S. Stevens
Researcher at National Health Laboratory Service
Publications - 156
Citations - 11695
Wendy S. Stevens is an academic researcher from National Health Laboratory Service. The author has contributed to research in topics: Viral load & Population. The author has an hindex of 44, co-authored 147 publications receiving 10184 citations. Previous affiliations of Wendy S. Stevens include University of the Witwatersrand.
Papers
More filters
Journal ArticleDOI
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Jared M. Baeten,Deborah Donnell,Deborah Donnell,Patrick Ndase,Nelly Mugo,Nelly Mugo,James D. Campbell,Jonathan Wangisi,Jordan W. Tappero,Elizabeth A. Bukusi,Craig R. Cohen,Elly Katabira,Allan R. Ronald,Allan R. Ronald,Elioda Tumwesigye,Edwin Were,Kenneth H. Fife,James Kiarie,James Kiarie,Carey Farquhar,Grace John-Stewart,Aloysious Kakia,Josephine Odoyo,Akasiima Mucunguzi,Edith Nakku-Joloba,Rogers Twesigye,Kenneth Ngure,Cosmas Apaka,Harrison Tamooh,Fridah Gabona,Andrew Mujugira,Dana Panteleeff,Katherine K. Thomas,Lara Kidoguchi,Meighan Krows,Jennifer Revall,Susan Morrison,Harald S. Haugen,Mira Emmanuel-Ogier,Lisa Ondrejcek,Robert W. Coombs,Lisa M. Frenkel,Lisa M. Frenkel,Craig W. Hendrix,Namandjé N. Bumpus,David R. Bangsberg,Jessica E. Haberer,Wendy S. Stevens,Jairam R. Lingappa,Connie Celum +49 more
TL;DR: Oral TDF and TDF-FTC both protect against HIV-1 infection in heterosexual men and women, and both study medications significantly reduced the HIV- 1 incidence among both men andWomen.
Journal ArticleDOI
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.
Deborah Donnell,Deborah Donnell,Jared M. Baeten,James Kiarie,James Kiarie,Katherine K. Thomas,Wendy S. Stevens,Craig R. Cohen,James McIntyre,Jairam R. Lingappa,Connie Celum +10 more
TL;DR: In this article, the effect of ART use by patients infected with HIV-1 on risk of transmission to their uninfected partners was evaluated in a randomised placebo-controlled trial that enrolled heterosexual African adults who were seropositive for both HIV and herpes simplex virus type 2.
Journal ArticleDOI
Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.
Connie Celum,Anna Wald,Anna Wald,J.R. Lingappa,Amalia Magaret,Amalia Magaret,Richard S. Wang,Nelly Mugo,Nelly Mugo,Andrew Mujugira,Jared M. Baeten,James I. Mullins,James P. Hughes,Elizabeth A. Bukusi,Elizabeth A. Bukusi,Elizabeth A. Bukusi,Craig R. Cohen,Elly Katabira,Allan R. Ronald,James Kiarie,Carey Farquhar,Grace John Stewart,Joseph Makhema,Myron Essex,Edwin Were,Kenneth H. Fife,G de Bruyn,Glenda Gray,James McIntyre,Rachel Manongi,Saidi Kapiga,David Coetzee,Susan Allen,Mubiana Inambao,Kayitesi Kayitenkore,Etienne Karita,William Kanweka,Sinead Delany,Helen Rees,Bellington Vwalika,Wendy S. Stevens,Campbell,Katherine K. Thomas,Robert W. Coombs,Rhoda Ashley Morrow,William L. H. Whittington,M J McElrath,M J McElrath,Linda E Barnes,Renee Ridzon,Lawrence Corey,Lawrence Corey +51 more
TL;DR: Daily acyclovir therapy did not reduce the risk of transmission of HIV-1, despite a reduction in plasma HIV- 1 RNA of 0.25 log(10) copies per milliliter and a 73% reduction in the occurrence of genital ulcers due to HSV-2.
Journal ArticleDOI
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study
Susan E. Dorman,Samuel G Schumacher,David Alland,Pamela Nabeta,Derek T. Armstrong,Bonnie S King,Sandra L. Hall,Soumitesh Chakravorty,Daniela Maria Cirillo,Nestani Tukvadze,Nino Bablishvili,Wendy S. Stevens,Lesley Scott,Camilla Rodrigues,Mubin Kazi,Moses Joloba,Lydia Nakiyingi,Mark P. Nicol,Mark P. Nicol,Yonas Ghebrekristos,Yonas Ghebrekristos,Irene Anyango,Wilfred Murithi,Reynaldo Dietze,Renata Lyrio Peres,Alena Skrahina,Vera Auchynka,Kamal Kishore Chopra,Mahmud Hanif,Xin Liu,Xing Yuan,Catharina Boehme,Jerrold J. Ellner,Claudia M. Denkinger,Yukari C. Manabe,David L. Hom,Rusudan Aspindzelashvili,Anura David,Utkarsha Surve,Louis Henry Kamulegeya,Sheila Nabweyambo,Shireen Surtie,Nchimunya Hapeela,Kevin P. Cain,Janet Agaya,Kimberly D. McCarthy,Patricia Marques-Rodrigues,Luiz Guilherme Schmidt Castellani,Pedro Sousa Almeida,Paola Poloni Lobo de Aguiar,Varvara Solodovnikova,Xianglin Ruan,Lili Liang,Guolong Zhang,Hong Zhu,Yingda Xie +55 more
TL;DR: For tuberculosis case detection, sensitivity ofXpert Ultra was superior to that of Xpert in Patients with paucibacillary disease and in patients with HIV, however, this increase in sensitivity came at the expense of a decrease in specificity.
Journal ArticleDOI
Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa
Houriiyah Tegally,Monika Moir,J.S. Everatt,Marta Giovanetti,Cathrine Scheepers,Eduan Wilkinson,Kathleen Subramoney,Zinhle Makatini,Sikhulile Moyo,Daniel G. Amoako,Cheryl Baxter,Christian L. Althaus,Ugochukwu J. Anyaneji,Dikeledi Kekana,Raquel Viana,Jennifer Giandhari,Richard J Lessells,Tongai Maponga,Dorcas Maruapula,Wonderful T. Choga,Mogomotsi Matshaba,M. Mbulawa,Nokukhanya Msomi,Yeshnee Naidoo,Sureshnee Pillay,Tomasz J. Sanko,James Emmanuel San,Lesley Scott,Lavanya Singh,Nonkululeko A Magini,P. Smith-Lawrence,Wendy S. Stevens,Graeme Dor,D. Tshiabuila,Nicole Wolter,Wolfgang Preiser,Florette K. Treurnicht,Marietjie Venter,G.E. Chiloane,Caitlyn McIntyre,Áine O'Toole,Christopher Ruis,Thomas P. Peacock,Cornelius Roemer,Sergei L. Kosakovsky Pond,Carolyn Williamson,Oliver G. Pybus,Jinal N. Bhiman,Allison J. Glass,Darren P. Martin,Ben Jackson,Andrew Rambaut,O. Laguda-Akingba,Simani Gaseitsiwe,Anne von Gottberg,Tulio de Oliveira +55 more
TL;DR: In this article , the authors identified two new lineages, BA.4 and BA.5, responsible for a fifth wave of infections in South Africa, by using a multinomial logistic regression model.